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Visceral aneurysms are rare in the general population (<2%), and the most serious complication is represented by
aneurysm rupture. The use of stent grafts to exclude visceral aneurysms is described in several reports but is reserved for
patients with favorable anatomy. We report here on a hepatic artery pseudoaneurysm in a liver transplant patient and
a patient with an aneurysmal vein graft degeneration of a renal bypass, both with no suitable proximal neck for standard
stent grafting. Both patients were successfully treated with a custom-made aortic endograft with a single fenestration for
the hepatic or renal artery, together with a visceral covered stent. Although initial results are promising, long-term follow-
up is required to assess durability. (J Vasc Surg 2013;58:1412-6.)Visceral artery aneurysms, both true and pseudoaneur-
ysms, are rare entities with an incidence at angiographic
series and autopsy ranging between 0.1% and 2%.1 The
most serious complication is represented by aneurysm
rupture, associated with patient mortality of 10% to 70%
in most reported studies.2-4 Surgical treatment is warranted
in case of symptoms and when the risk of rupture is deemed
high, depending on aneurysm size, location, etiology, and
associated conditions. False aneurysms may be at a higher
risk of rupture due to the lack of a continuous adventitial
layer in the outer wall. Aneurysms developing after
previous surgical treatment offer an extreme surgical
challenge due to the presence of adhesions and the risk
of iatrogenic injuries and intraoperative rupture.
Several reports have described the successful use of
stent grafts to seal visceral aneurysms, but they are usually
reserved for few patients presenting with a favorable
anatomy. The technique described in this report represents
a novel solution for endovascular visceral aneurysm exclu-
sion in the setting of vessel dilations with no proximal
sealing zone at the level of the proximal aortic origin.
We report two cases of late development of aneurysmal
evolution. The ﬁrst case was a hepatic artery homograft inthe Unit of Vascular and Endovascular Surgery, Ospedale S. Maria
lla Misericordia, Università degli Studi di Perugia, Perugiaa; and the
nit of Vascular Surgery, Department of Cardiosciences, Ospedale S.
amillo-Forlanini, Rome.b
or conﬂict of interest: none.
rint requests: Fabio Verzini, MD, PhD, FEBVS, Unit of Vascular and
dovascular Surgery, Ospedale S. Maria della Misericordia, Piazzale
enghini, 1, 06132 Perugia, Italy (e-mail: fverzini@unipg.it).
editors and reviewers of this article have no relevant ﬁnancial relationships
disclose per the JVS policy that requires reviewers to decline review of any
anuscript for which they may have a conﬂict of interest.
-5214/$36.00
yright  2013 by the Society for Vascular Surgery.
://dx.doi.org/10.1016/j.jvs.2013.05.045
2a liver transplant patient, and the second was a vein graft
renal bypass. Both patients were treated with this endovas-
cular option.
CASE REPORT
Patient 1. A 53-year-old man had an orthotopic liver trans-
plant for end-stage liver disease secondary to cirrhosis. The donor
iliac artery was used as a free arterial graft anastomosed to the
recipient patient’s abdominal aorta in an end-to-side fashion and
end-to-end to the hepatic artery. After 20 years, the patient was
doingwell, with almost normal function liver tests, apart from amild
increase of serum aspartate aminotransferase and alanine amino-
transferase. A contrast-enhanced computed tomography (CT)
follow-up scan conﬁrmed the presence of a 4-cm hepatic artery
pseudoaneurysm, partially thrombosed extending for 6 cm in length
from the aortic anastomosis to the distal hepatic artery, suspected at
a routine echographic control (Fig 1).
To treat the aneurysm, which showed no proximal aneurysm
neck suitable for a regular stent graft, a custom-made tubular aortic
endograft (Cook Inc, Bloomington, Ind) with a single fenestration
for the transplanted hepatic artery was designed. The procedure
was done under local anesthesia in a hybrid operating room equip-
ped with a ﬁxed, ceiling-mounted, angiography machine with a ﬂat
panel. After a bilateral femoral cutdown, the aortic endograft was
partially deployed into the infrarenal aorta, mating the fenestration
with the dilated ostium of the visceral aneurysm. After wire cannu-
lation of the fenestration and the aneurysmal hepatic artery
through a femoral access, the aortic graft was fully expanded,
and two covered Viabahn stent grafts (W. L. Gore and Associates
Inc, Newark, Del) were deployed from the hepatic aneurysm neck.
Proximally, a balloon-expandable Advanta V12 stent graft (Atrium,
Hudson, NH) was deployed so that most of the stent was anchored
within the Viabahn andw5mmof the proximal stent extended into
the aorta through the fenestration. Flaring of the proximal (aortic)
end of the stent was achieved with a 12-mm-diameter balloon.
Fig 1. A, Axial computed tomography (CT) image shows a hepatic pseudoaneurysm at the proximal aortic anasto-
mosis. B, A three-dimensional CT reconstruction illustrates the partially thrombosed (red) pseudoaneurysm.
Fig 2. Intraoperative angiogram is shown (A) after partial deployment of a fenestrated aortic endograft and wiring of
the transplanted hepatic artery through the fenestration and (B) a completion angiogram after aortic and hepatic
endografting in the same patient as in Fig 1.
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endograft with no endoleaks (Fig 2).
The patient was discharged on postoperative day 4, without
complications, on antiplatelet therapy. Duplex ultrasound imaging
follow-up showed a normal hepatic ﬂow pattern. A CT scan at
1 and 8 months showed a widely patent extrahepatic and intrahe-
patic artery and total exclusion of the pseudoaneurysm sac (Fig 3).
At the 11-month follow-up, liver function tests were within normal
reference ranges, and a duplex ultrasound scan conﬁrmed aneurysm
exclusion and regular ﬂow to the hepatic artery.
Patient 2. In 1973, a 19-year-old woman had an aortorenal
bypass with reversed saphenous vein graft for ﬁbromuscular
dysplasia. When she was 55, a duplex ultrasound follow-up scan
revealed aneurysmal degeneration of the vein graft, with a
maximum diameter of 4 cm (Fig 4). Because the aneurysm
presented a suitable distal landing zone but a dilated aortic origin,
a custom-made aortic endograft (Cook Inc) was designed with
a single fenestration for the aneurysm of the renal artery. The
aortic endograft was deployed with general anesthesia and singlefemoral cutdown. Two covered Advanta stent grafts were then
deployed from distal to proximal through the fenestration to
exclude the renal aneurysm, and the proximal end was ﬂared to
reinforce the proximal sealing at the level of fenestration. An
intraoperative angiogram showed patency of aorta and renal artery
with no endoleaks.
The patient was discharged after 2 days, and no perioperative
complications were recorded. Renal function was normal, with
a creatinine serum level of 0.9mg/dL.During the following 3 years,
duplex ultrasound and CT examinations conﬁrmed persisting
patency of the stent grafts and renal aneurysm exclusion (Fig 5).
Serum creatinine levels remained within normal reference ranges.
DISCUSSION
The incidence of hepatic artery pseudoaneurysm is 1%
to 2% in all liver transplant patients5,6; standard surgical
treatment is associated with mortality rates as high as
69%. The development of aneurysm degeneration of
previous aortorenal saphenous vein bypasses is even more
Fig 3. A, An axial computed tomography (CT) image in the same patient as in Fig 1 after 8 months from treatment
shows patency of aortic and hepatic endograft in the absence of endoleak. B, A three-dimensional reconstruction of the
same CT scan shows additional details.
Fig 4. A, An axial computed tomography (CT) image shows vein graft aneurysmal degeneration. B, A three-
dimensional CT reconstruction illustrates the vein graft aneurysm.
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1985, Stanley et al7 reported three (1%) such patients, all
requiring surgical revision.
Endovascular treatment may offer several advantages
compared with traditional surgical repair due to its minimal
invasiveness. Coil embolization of the aneurysm is usually
technically feasible in saccular aneurysms, but the risk of
coil migration still remains a concern.8 Early recanalization
of the aneurysm can occur.
Exclusion of aneurysm or pseudoaneurysm by endovas-
cular grafts has been increasingly adopted, as highlighted in
current reports.9-13 Covered stents offer the advantage of a
minimally invasive treatment, maintaining vessel patency
and end-organ perfusion, but there are often contraindica-
tions because of the patient’s arterial anatomy. Require-
ments for stent grafting are the presence of suitable sealing
zones proximally and distally to the aneurysm, the absence
of a critical vessel takeoff from the aneurysm sac to be
excluded, and an arterial access that permits safe navigationof the stent graft deployment system to the target location.
With these requirements, treatment of visceral aneurysms
secondary to organ transplants or previous visceral bypass
often entails challenging open surgical solutions.
Even in the most recent published reports, the favored
endovascular treatment option for visceral aneurysms is still
characterized by coil or glue exclusion, often associated with
feeding vessel obstruction.9-13 In a three-center experience
from the Mayo Clinic reporting 185 aneurysms treated
during a 10-year period, simple endovascular coiling repre-
sented the sole treatment in 78%, and covered stent alone
was used in 5%. Fankhauser et al10 reported a 30-day
mortality rate of 6.2%, due to bleeding in half of the patients.
In the present patients, to create a proximal sealing
zone for the stent graft in visceral aneurysms with a dilated
aortic origin, a custom-made aortic endograft with a single
fenestration for the hepatic or renal aneurysmatic artery was
designed and placed into the aorta. In both patients,
a 6-mm circular fenestration was used, mating the visceral
Fig 5. A, An axial computed tomography (CT) image in the same patient as in Fig 4 after 31 months from treatment
shows patency of aortic and renal endograft in absence of endoleak. B, A three-dimensional reconstruction of the same
CT scan shows additional details.
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constraints, possible fenestration diameters can range
between 6 and 8 mm, without the risk of a stent strut
crossing the fenestration. The location should be placed
at least 15 mm away from the end of the graft. The aortic
component is usually chosen with an oversize of 10%
compared with the aortic diameter and with a total length
of at least 40 mm to accommodate two aortic stents.
To seal the visceral aneurysm, precise deployment of
a single stent graft of the exact length needed is rarely
possible; therefore, a better solution of two stents partially
overlapping may be more useful. Of note, the preferred
proximal stent graft should be a balloon-expandable
covered stent that can be ﬂared with an oversized balloon
to enhance ﬁxation and sealing. In case of vessel tortuosity,
the distal segment may be represented by a more ﬂexible
self-expanding stent graft.
This technique has limitations due to anatomic
constraints. The use of an aortic endograft requires large-
bore introducer systems and suitable iliac access arteries.
There must be an aortic sealing zone for the fenestrated
graft proximally and distally to the fenestration of at least
15 mm in length; otherwise, a multiple fenestration graft
could be used. Absolute contraindication to this endovas-
cular treatment is aneurysm rupture or the need of urgent
treatment in which time delay to obtain a suitable fenes-
trated endograft cannot be tolerated.
Other contraindications are represented by patient
intolerance to stainless steel, nitinol, gold, polyester,
polypropylene, or medium contrast. Moreover, patients
with septic aneurysms or high septic risks might be
better addressed by open surgical repair with autogenous
grafts.
In our experience, aneurysm exclusion and end-organ
perfusion was successfully obtained in both patients in
the midterm, without postoperative complications and
with a short hospital stay. Our patients were treated indef-
initely with single antiplatelet therapy with 100 mg/d ofacetylsalicylic acid and followed up with duplex ultrasound
imaging before hospital discharge and every 6 months
thereafter. A CT scan was scheduled at 1 month and yearly
postoperatively.
CONCLUSIONS
Endovascular visceral aneurysm exclusion with aortic
fenestrated endograft coupled with visceral covered stent
may represent a favorable treatment option for patients
without a suitable proximal neck. Although the initial
results are promising, a longer follow-up is required to assess
the durability of repair.REFERENCES
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